日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/16 | 6,373 | 6,514 | 6,361 | 6,467 | +89 | +1.4% | 504,000 |
| 2023/06/15 | 6,455 | 6,505 | 6,378 | 6,378 | -125 | -1.9% | 287,200 |
| 2023/06/14 | 6,547 | 6,586 | 6,450 | 6,503 | -37 | -0.6% | 344,400 |
| 2023/06/13 | 6,597 | 6,683 | 6,516 | 6,540 | -21 | -0.3% | 436,200 |
| 2023/06/12 | 6,516 | 6,672 | 6,513 | 6,561 | +77 | +1.2% | 256,000 |
| 2023/06/09 | 6,516 | 6,546 | 6,453 | 6,484 | +68 | +1.1% | 257,600 |
| 2023/06/08 | 6,561 | 6,574 | 6,387 | 6,416 | -124 | -1.9% | 228,500 |
| 2023/06/07 | 6,676 | 6,694 | 6,513 | 6,540 | -69 | -1% | 275,500 |
| 2023/06/06 | 6,515 | 6,625 | 6,482 | 6,609 | +53 | +0.8% | 224,400 |
| 2023/06/05 | 6,615 | 6,624 | 6,501 | 6,556 | +6 | +0.1% | 371,500 |
| 2023/06/02 | 6,500 | 6,600 | 6,450 | 6,550 | +140 | +2.2% | 281,100 |
| 2023/06/01 | 6,450 | 6,470 | 6,380 | 6,410 | +30 | +0.5% | 214,200 |
| 2023/05/31 | 6,290 | 6,440 | 6,280 | 6,380 | ±0 | ±0% | 584,400 |
| 2023/05/30 | 6,420 | 6,510 | 6,320 | 6,380 | -40 | -0.6% | 178,600 |
| 2023/05/29 | 6,500 | 6,510 | 6,390 | 6,420 | -20 | -0.3% | 207,600 |
| 2023/05/26 | 6,470 | 6,500 | 6,410 | 6,440 | -100 | -1.5% | 239,700 |
| 2023/05/25 | 6,600 | 6,710 | 6,540 | 6,540 | +90 | +1.4% | 387,800 |
| 2023/05/24 | 6,530 | 6,540 | 6,450 | 6,450 | -60 | -0.9% | 236,700 |
| 2023/05/23 | 6,550 | 6,580 | 6,480 | 6,510 | +80 | +1.2% | 231,700 |
| 2023/05/22 | 6,460 | 6,480 | 6,380 | 6,430 | +20 | +0.3% | 166,200 |
| 2023/05/19 | 6,350 | 6,430 | 6,320 | 6,410 | +60 | +0.9% | 258,400 |
| 2023/05/18 | 6,430 | 6,450 | 6,300 | 6,350 | -10 | -0.2% | 260,400 |
| 2023/05/17 | 6,400 | 6,440 | 6,350 | 6,360 | -40 | -0.6% | 276,900 |
| 2023/05/16 | 6,210 | 6,400 | 6,170 | 6,400 | +200 | +3.2% | 402,100 |
| 2023/05/15 | 6,160 | 6,210 | 6,150 | 6,200 | -10 | -0.2% | 257,300 |
| 2023/05/12 | 6,200 | 6,280 | 6,070 | 6,210 | +50 | +0.8% | 396,300 |
| 2023/05/11 | 6,160 | 6,210 | 6,150 | 6,160 | -60 | -1% | 171,200 |
| 2023/05/10 | 6,280 | 6,290 | 6,200 | 6,220 | -70 | -1.1% | 169,700 |
| 2023/05/09 | 6,240 | 6,310 | 6,230 | 6,290 | +60 | +1% | 184,900 |
| 2023/05/08 | 6,290 | 6,290 | 6,190 | 6,230 | ±0 | ±0% | 204,500 |
| 2023/05/02 | 6,300 | 6,320 | 6,190 | 6,230 | -40 | -0.6% | 148,500 |
| 2023/05/01 | 6,260 | 6,290 | 6,220 | 6,270 | +70 | +1.1% | 199,800 |
| 2023/04/28 | 6,190 | 6,260 | 6,180 | 6,200 | +70 | +1.1% | 205,800 |
| 2023/04/27 | 6,090 | 6,140 | 6,060 | 6,130 | -10 | -0.2% | 157,800 |
| 2023/04/26 | 6,200 | 6,270 | 6,120 | 6,140 | -100 | -1.6% | 280,700 |
| 2023/04/25 | 6,180 | 6,290 | 6,140 | 6,240 | +60 | +1% | 271,300 |
| 2023/04/24 | 6,220 | 6,240 | 6,160 | 6,180 | -10 | -0.2% | 245,500 |
| 2023/04/21 | 6,070 | 6,250 | 6,040 | 6,190 | +120 | +2% | 342,100 |
| 2023/04/20 | 6,230 | 6,230 | 6,010 | 6,070 | +20 | +0.3% | 353,800 |
| 2023/04/19 | 6,020 | 6,110 | 5,980 | 6,050 | -70 | -1.1% | 273,000 |
| 2023/04/18 | 6,160 | 6,230 | 6,090 | 6,120 | +40 | +0.7% | 262,400 |
| 2023/04/17 | 6,150 | 6,230 | 6,060 | 6,080 | -130 | -2.1% | 342,300 |
| 2023/04/14 | 6,220 | 6,270 | 6,160 | 6,210 | +290 | +4.9% | 728,100 |
| 2023/04/13 | 5,830 | 5,930 | 5,810 | 5,920 | +60 | +1% | 345,300 |
| 2023/04/12 | 5,830 | 5,880 | 5,820 | 5,860 | +110 | +1.9% | 413,700 |
| 2023/04/11 | 5,750 | 5,800 | 5,710 | 5,750 | ±0 | ±0% | 235,000 |
| 2023/04/10 | 5,730 | 5,750 | 5,700 | 5,750 | +50 | +0.9% | 185,800 |
| 2023/04/07 | 5,790 | 5,790 | 5,690 | 5,700 | -50 | -0.9% | 160,600 |
| 2023/04/06 | 5,690 | 5,770 | 5,650 | 5,750 | +40 | +0.7% | 301,200 |
| 2023/04/05 | 5,900 | 5,900 | 5,710 | 5,710 | -190 | -3.2% | 242,400 |
551～
600
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 374,400円 | +3.8% | -19.9% | 3.63% | 12.16倍 | 0.93倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 203,400円 | +5.9% | +684.6% | 2.70% | 13.50倍 | 1.35倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
